Deka Bank Deutsche Girozentrale Iovance Biotherapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 100,000 shares of IOVA stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,000

Previous 100,000 -0.0%

Holding current value

$1.1 Million

Previous $797,000 19.95%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$9.53 - $13.11 $227,766 - $313,329	-23,900 Reduced 19.29%	100,000 $942,000
Q1 2022 Apr 28, 2022	BUY	$12.38 - $19.1 $139,894 - $215,830	11,300 Added 10.04%	123,900 $2.07 Million
Q4 2021 Feb 02, 2022	SELL	$16.55 - $27.63 $248,250 - $414,450	-15,000 Reduced 11.76%	112,600 $2.17 Million
Q2 2021 Aug 05, 2021	BUY	$16.33 - $33.07 $1.05 Million - $2.12 Million	64,000 Added 100.63%	127,600 $3.34 Million
Q4 2020 Mar 12, 2021	BUY	$28.04 - $50.26 $1 Million - $1.8 Million	35,800 Added 128.78%	63,600 $3.05 Million
Q3 2020 Oct 29, 2020	BUY	$27.75 - $36.3 $771,450 - $1.01 Million	27,800 New	27,800 $894,000
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $1.96 Million - $2.83 Million	-109,000 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$9.78 - $24.52 $185,820 - $465,880	19,000 Added 21.11%	109,000 $2.46 Million
Q1 2019 May 10, 2019	BUY	$8.41 - $11.26 $483,575 - $647,450	57,500 Added 176.92%	90,000 $1.59 Million
Q4 2018 Feb 12, 2019	SELL	$7.51 - $11.93 $431,825 - $685,975	-57,500 Reduced 63.89%	32,500 $288,000
Q3 2018 Nov 09, 2018	SELL	$11.25 - $17.7 $27,000 - $42,480	-2,400 Reduced 2.6%	90,000 $0
Q2 2018 Aug 14, 2018	BUY	$12.45 - $16.95 $622,500 - $847,500	50,000 Added 117.92%	92,400 $1.2 Million
Q1 2018 May 03, 2018	BUY	$8.1 - $19.5 $343,440 - $826,800	42,400 New	42,400 $700,000

Others Institutions Holding IOVA

# of Institutions

320

Shares Held

238M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Iovance Biotherapeutics, Inc. Transaction History